Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bileacid Malabsorption and GLP-1 Secretion
NCT03009916Phase 4Completed
- Sponsor
- Gentofte Hospital
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colesevelam in bile acid malabsorption (BAM), sponsored by Gentofte Hospital. Started Mar 2016; status: completed.
02
Drugs
colesevelam
03
Conditions
bile acid malabsorption (BAM)
Beyond the preview
Go deeper on NCT03009916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03009916.